Academic Clinical Trials
|
UHKT-CAML-NK-01 "Adoptive transfer of haploidentical ex-vivo expanded NK cells to patients with refractory or relapsed acute myeloid leukemia in allogeneic hematopoietic stem cell transplantation from a haploidentical related donor following a sequential preparatory protocol. A monocentric, open-label, phase IIa study with escalating dosing." |
Finished |
|
UHKT-VSL-CCS-01 "Efficiency of production, clinical safety and efficacy of virus-specific T lymphocytes isolated on the CliniMACS Prodigy® device using the Cytokine Capture system for patients after allogeneic transplantation." |
Finished |
|
TCB-202-001 "Clinical evaluation of the safety and efficacy of allogeneic γδ T-lymphocytes expanded ex vivo (OmnImmune®) in patients with relapsed or refractory acute myeloid leukemia (AML) who are unable or unwilling to undergo high-dose rescue chemotherapy and/or allogeneic hematopoietic cell transplantation. An open-label, dose escalating phase I study." |
Finished |
|
UHKT-CAR19-01 "Clinical evaluation of the safety and efficacy of autologous CART19 lymphocytes in patients with relapsed or refractory acute B-lymphoblastic leukemia (B-ALL) or relapsed or refractory B-cell non-Hodgkin's lymphoma (B-NHL). An open-label, dose-escalating phase I study." |
Open |
|
UHKT-CAR123-01 "Safety and efficacy of autologous T lymphocytes with chimeric anti-CD123 antigen receptor in patients with relapsed or refractory CD123-positive hematologic malignancies. An open-label, dose-escalating phase I study." |
Open |